Pancreas specific promoter driven Cre recombinase (Pdx1-Cre) induced expression of activated KRas and mutant p53 within the pancreas are currently the most appropriate genetically engineered murine model of pancreatic cancer. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.